Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Multiparametric magnetic resonance imaging-guided salvage radiotherapy in prostate cancer.

Couñago F, Díaz Gavela AA, Sancho G, Ortiz I, Marcos FJ, Recio M, Fernández J, Cano R, Jiménez M, Thuissard IJ, Sanz-Rosa D, Castro Nováis J, Pardo E, Molina Y, Pérez García H, Del Cerro E.

Rep Pract Oncol Radiother. 2019 Sep-Oct;24(5):472-480. doi: 10.1016/j.rpor.2019.07.008. Epub 2019 Aug 8.

PMID:
31452628
2.

Multiparametric Magnetic Resonance Imaging Is an Independent Predictor of Salvage Radiotherapy Outcomes After Radical Prostatectomy.

Sharma V, Nehra A, Colicchia M, Westerman ME, Kawashima A, Froemming AT, Kwon ED, Mynderse LA, Karnes RJ.

Eur Urol. 2018 Jun;73(6):879-887. doi: 10.1016/j.eururo.2017.11.012. Epub 2017 Nov 28.

PMID:
29195777
3.

Evaluation of tumor recurrences after radical prostatectomy using 18F-Choline PET/CT and 3T multiparametric MRI without endorectal coil: a single center experience.

Couñago F, Recio M, Maldonado A, Del Cerro E, Díaz-Gavela AA, Thuissard IJ, Sanz-Rosa D, Marcos FJ, Olaciregui K, Mateo M, Cerezo L.

Cancer Imaging. 2016 Dec 7;16(1):42.

4.

Outcome after PSMA PET/CT based salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: a bi-institutional retrospective analysis.

Schmidt-Hegemann NS, Stief C, Kim TH, Eze C, Kirste S, Strouthos I, Li M, Schultze-Seemann W, Ilhan H, Fendler WP, Bartenstein P, Grosu AL, Ganswindt U, Belka C, Meyer PT, Zamboglou C.

J Nucl Med. 2018 Jul 12. pii: jnumed.118.212563. doi: 10.2967/jnumed.118.212563. [Epub ahead of print]

5.

Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.

Kupelian PA, Katcher J, Levin HS, Klein EA.

Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1043-52.

PMID:
9169811
6.

Disease Control With Delayed Salvage Radiotherapy for Macroscopic Local Recurrence Following Radical Prostatectomy.

Shelan M, Odermatt S, Bojaxhiu B, Nguyen DP, Thalmann GN, Aebersold DM, Dal Pra A.

Front Oncol. 2019 Feb 28;9:12. doi: 10.3389/fonc.2019.00012. eCollection 2019.

7.

Magnetic resonance imaging for prostate cancer before radical and salvage radiotherapy: What radiation oncologists need to know.

Couñago F, Sancho G, Catalá V, Hernández D, Recio M, Montemuiño S, Hernández JA, Maldonado A, Del Cerro E.

World J Clin Oncol. 2017 Aug 10;8(4):305-319. doi: 10.5306/wjco.v8.i4.305. Review.

8.

Multiparametric magnetic resonance imaging-transrectal ultrasound fusion-assisted biopsy for the diagnosis of local recurrence after radical prostatectomy.

Muller BG, Kaushal A, Sankineni S, Lita E, Hoang AN, George AK, Rais-Bahrami S, Kruecker J, Yan P, Xu S, de la Rosette JJ, Merino MJ, Wood BJ, Pinto PA, Choyke PL, Turkbey B.

Urol Oncol. 2015 Oct;33(10):425.e1-425.e6. doi: 10.1016/j.urolonc.2015.05.021. Epub 2015 Aug 8.

9.

Importance of the site of positive surgical margin in salvage external beam radiation therapy for biochemical recurrence of prostate cancer after radical prostatectomy.

Kashihara T, Nakamura S, Wakita A, Okamoto H, Inaba K, Umezawa R, Shima S, Tsuchida K, Kobayashi K, Takahashi K, Murakami N, Ito Y, Igaki H, Fujimoto H, Uno T, Itami J.

Cancer Med. 2018 May;7(5):1723-1730. doi: 10.1002/cam4.1408. Epub 2018 Mar 23.

10.

Dose-escalated salvage radiotherapy after radical prostatectomy in high risk prostate cancer patients without hormone therapy: outcome, prognostic factors and late toxicity.

Shelan M, Abo-Madyan Y, Welzel G, Bolenz C, Kosakowski J, Behnam N, Wenz F, Lohr F.

Radiat Oncol. 2013 Nov 27;8:276. doi: 10.1186/1748-717X-8-276.

11.

Recurrent prostate cancer after radical prostatectomy: restaging performance of 18F-choline hybrid PET/MRI.

Achard V, Lamanna G, Denis A, De Perrot T, Mainta IC, Ratib O, Iselin C, Miralbell R, Garibotto V, Zilli T.

Med Oncol. 2019 Jun 12;36(8):67. doi: 10.1007/s12032-019-1291-z.

PMID:
31190232
12.

Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy.

Buchser D, Gomez-Iturriaga A, Melcon JI, Casquero F, Llarena R, Cacicedo J, Bilbao P.

J Contemp Brachytherapy. 2016 Dec;8(6):477-483. doi: 10.5114/jcb.2016.64441. Epub 2016 Dec 6.

13.

Adjuvant versus salvage radiotherapy in prostate cancer: multi-institutional retrospective analysis of the Spanish RECAP database.

Hervás A, Gómez-Caamaño A, Casaña M, Gómez-Iturriaga A, Pastor J, Jove J, Mengual JL, Gónzalez-San Segundo C, Muñoz J.

Clin Transl Oncol. 2018 Feb;20(2):193-200. doi: 10.1007/s12094-017-1709-z. Epub 2017 Jun 30.

PMID:
28667448
14.

68Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning.

Calais J, Czernin J, Cao M, Kishan AU, Hegde JV, Shaverdian N, Sandler K, Chu FI, King CR, Steinberg ML, Rauscher I, Schmidt-Hegemann NS, Poeppel T, Hetkamp P, Ceci F, Herrmann K, Fendler WP, Eiber M, Nickols NG.

J Nucl Med. 2018 Feb;59(2):230-237. doi: 10.2967/jnumed.117.201749. Epub 2017 Nov 9.

15.

Proposal for magnetic resonance imaging-guided salvage radiotherapy for prostate cancer.

Dirix P, van Walle L, Deckers F, Van Mieghem F, Buelens G, Meijnders P, Huget P, Van Laere S.

Acta Oncol. 2017 Jan;56(1):27-32. doi: 10.1080/0284186X.2016.1223342. Epub 2016 Sep 1.

PMID:
27587084
16.

Oncological Outcome and Value of Postoperative Magnetic Resonance Imaging after Focal High-Intensity Focused Ultrasound Therapy for Prostate Cancer.

Rosenhammer B, Niessen C, Rotzinger L, Reiss J, Schnabel MJ, Burger M, Bründl J.

Urol Int. 2019 Aug 29:1-9. doi: 10.1159/000502553. [Epub ahead of print]

PMID:
31466073
17.
18.

Early salvage radiation therapy combined with short-term hormonal therapy in recurrent prostate cancer after radical prostatectomy: single-institution 4-year data on outcome, toxicity, health-related quality of life and co-morbidities from 184 consecutive patients treated with 70 Gy.

Cortés-González JR, Castellanos E, Sandberg K, Eriksson MH, Wiklund P, Carlsson S, Cohn-Cedermark G, Harmenberg U, Gustafsson O, Levitt SH, Lennernäs B, Brandberg Y, Márquez M, Kälkner KM, Nilsson S.

Int J Oncol. 2013 Jan;42(1):109-17. doi: 10.3892/ijo.2012.1694. Epub 2012 Nov 13.

PMID:
23151842
19.

Pretreatment 3T multiparametric MRI staging predicts for biochemical failure in high-risk prostate cancer treated with combination high-dose-rate brachytherapy and external beam radiotherapy.

Hegde JV, Demanes DJ, Veruttipong D, Raince J, Park SJ, Raman SS, Nickols NG, King CR, Kishan AU, Steinberg ML, Kamrava M.

Brachytherapy. 2017 Nov - Dec;16(6):1106-1112. doi: 10.1016/j.brachy.2017.07.008. Epub 2017 Aug 12.

PMID:
28807747
20.

Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.

Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):714-24.

PMID:
15708249

Supplemental Content

Support Center